Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Citius Oncology, Inc.

NASDAQ: CTOR · Life Sciences · 4 alerts · CIK 1851484

Share price
$0.5350Close, Nov 16
Market cap
$49.7M
Shares outstanding
92.98MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Citius Oncology, Inc. filings on SEC EDGAR ↗

4:06 PM ET 8-K
Business Update

Citius Oncology Business Update

Citius Oncology reported preliminary fiscal fourth quarter 2026 operational metrics for its drug LYMPHIR, showing a 120% increase in unit sales to U.S. wholesalers compared to the prior quarter. The company reached 792 units sold to wholesalers and expanded its institutional reach to 54 prescribing centers as of late October.

Term
Q4 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.